Liminatus Pharma, Inc. - LIMN
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$292K
QoQ value delta ($000)
+$103K
(+54.5%)
Implied price effect (QoQ)
-68.36%
Shares
Total shares
1,548,862
QoQ shares delta
+1,231,669
(+388.3%)
Total shares held by funds (by quarter)
Market chart (LIMN)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 15 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| CITADEL ADVISORS LLC | 116 | 677,518 | 0.0% |
| Cygnus Capital Advisors, LLC | 60 | 350,000 | 0.04% |
| VANGUARD GROUP INC | 44 | 73,424 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 20 | 117,783 | 0.0% |
| JANE STREET GROUP, LLC | 12 | 71,318 | 0.0% |
| UBS Group AG | 9 | 54,578 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 8 | 50,440 | 0.0% |
| Virtu Financial LLC | 5 | 27,468 | 0.0% |
| Vanguard Personalized Indexing Management, LLC | 5 | 34,706 | 0.0% |
| STATE STREET CORP | 3 | 19,000 | 0.0% |
| TWO SIGMA SECURITIES, LLC | 3 | 22,039 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 3 | 22,984 | 0.0% |
| BlackRock, Inc. | 2 | 13,254 | 0.0% |
| CITIGROUP INC | 1 | 6,769 | 0.0% |
| Tower Research Capital LLC (TRC) | 1 | 7,567 | 0.0% |
| Farther Finance Advisors, LLC | 0 | 14 | 0.0% |